Metastatic Malignant Neoplasm to the Leptomeninges Not Yet Recruiting Phase 4 Trials for Durvalumab (DB11714)

Also known as: Leptomeningeal Metastasis / Neoplastic Meningitis / Leptomeningeal Metastases / Metastatic Malignant Neoplasm in the Leptomeninges / Leptomeningeal Disease (LMD) / Leptomeningeal Disease / Lymphomatous meningitis / Leptomeningeal Carcinomatosis / Metastatic malignant neoplasm to leptomeninges (disorder) / Lymphomatous meningitis (disorder) / Malignant meningitis (disorder) / Leptomeningeal Neoplasms / Meningeal dissemination / Metastases to meninges / Meningeal Carcinomatosis

DBCOND0057483 (Metastatic Malignant Neoplasm to the Leptomeninges)Not Yet Recruiting4 IdentifierTitlePurposeDrugs
NCT04356222Efficacy and Safety of Durvalumab in Non-Small Cell Lung Cancer With Leptomeningeal MetastasisTreatment